Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-047559
Filing Date
2017-08-03
Accepted
2017-08-03 20:22:24
Documents
2
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2150
2 POA DOCUMENT poa.txt EX-24.3_739049 4066
  Complete submission text file 0001209191-17-047559.txt   7859
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Joseph Donald (Reporting) CIK: 0001319460 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 171006643